Disrupted in Renal Carcinoma 2 (DIRC2) Peptide
DIRC2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all DIRC2 products
- DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- AAESSRAHIK DRIEAVLYAE FGVVCLIFSA TLAYFPPRPP LPPSVAAASQ
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DIRC2 antibody,
Alternative Names: DIRC2 control peptide, DIRC2 antibody Blocking Peptide, Anti-DIRC2 Blocking Peptide, Disrupted In Renal Carcinoma 2 Blocking Peptide, FLJ14784 Blocking Peptide, RCC4 Blocking Peptide, DIRC2, DIRC-2, DIRC 2, DIRC-2 Blocking Peptide, DIRC 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))
- Synonyms
- MGC80843 Peptide, zgc:92095 Peptide, rcc4 Peptide, MGC69320 Peptide, RCC4 Peptide, disrupted in renal carcinoma 2 Peptide, disrupted in renal carcinoma 2 L homeolog Peptide, disrupted in renal carcinoma 2 (human) Peptide, DIRC2 Peptide, dirc2.L Peptide, dirc2 Peptide, Dirc2 Peptide
- Background
- DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.
- Molecular Weight
- 52 kDa
-
You are here:
